(Q58864005)

English

Sulbactam-cefoperazone polyhydroxybutyrate-co- hydroxyvalerate (PHBV) local antibiotic delivery system:In vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis

scientific article published on 01 September 1999

  • Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: in vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis
In more languages
default for all languages
No label defined

No description defined

Statements

Sulbactam-cefoperazone polyhydroxybutyrate-co- hydroxyvalerate (PHBV) local antibiotic delivery system:In vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis (English)
0 references
Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: in vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis (English)
M. Firat Yagmurlu
0 references
Feza Korkusuz
0 references
Ihsan G�rsel
0 references
Petek Korkusuz
0 references
�lken �rs
0 references
Vasif Hasirci
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit